Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0368 | ||||
Gene Name | SLC45A1 | ||||
Protein Name | Proton-associated sugar transporter A | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | DNB5; DNb-5; Deleted in neuroblastoma 5 protein; IDDNPF; PAST-A; SLC45A1; Solute carrier family 45 member 1 | ||||
DT Family | Glycoside-Pentoside-Hexuronide (GPH):Cation Symporter Family ; | ||||
Tissue Specificity | Expressed in adult heart, brain, muscle andkidney, with very strong expression in brain. Also expressed infetal brain, kidney and lung. | ||||
Function | This transporter mediates the transport of proton-associated glucose in the brain. | ||||
Endogenous Substrate(s) | Glucose; Galactose; Sucrose | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
2-Deoxyglucose
|
Phase 1/2 | Drug Info | Cancer | 2A00-2F9Z | [1] |
References | |||||
1 | Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy. Am J Hum Genet. 2017 May 4;100(5):824-830. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.